An experimental single-stranded oligonucleotide-based drug, MGN1703, comprised only of natural DNA components, stimulates the human immune system to fight infections and attack cancer cells without causing the harmful side effects associated with similar compounds that also contain non-natural DNA components.
from The Medical News http://ift.tt/1CwnjAX
from The Medical News http://ift.tt/1CwnjAX
No comments:
Post a Comment